Prevention and control of meningococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP)

Baker, Carol J.; Briere, Elizabeth Z.; Clark, Thomas A.; Cohn, Amanda C.; MacNeil, Jessica R.; Meissner, H. Cody; Messonnier, Nancy E.; Ortega-Sanchez, Ismael R.

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

File Format:

RIS

Prevention and control of meningococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP)

Published Date:

March 22, 2013

Status:

current

Series:

Morbidity and mortality weekly report. Recommendations and reports, v. 62, no. RR-2 ; MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 62, no. RR-2 ;

Language:

English

[PDF-25.30 MB]

Viewer
Details
Supporting Files
Related Documents
You May Also Like

This document cannot be previewed automatically as it exceeds 5 MB

Please click the thumbnail image to view the document.

Prevention and control of meningococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP)

Details:

Personal Author:

Baker, Carol J. ; Briere, Elizabeth Z. ; Clark, Thomas A. ; Cohn, Amanda C. ; MacNeil, Jessica R. ; ... More ▼

Baker, Carol J. ; Briere, Elizabeth Z. ; Clark, Thomas A. ; Cohn, Amanda C. ; MacNeil, Jessica R. ; Meissner, H. Cody ; Messonnier, Nancy E. ; Ortega-Sanchez, Ismael R. Less ▲

Corporate Authors:

United States. Advisory Committee on Immunization Practices. ; Centers for Disease Control and Prevention (U.S.) ; National Center for Immunization and Respiratory Diseases (U.S.), Division of Bacterial Diseases. ;

Description:

Introduction -- Methods -- Background -- Meningococcal vaccines -- Postlicensure safety surveillance for meningococcal conjugate vaccines -- Cost-effectiveness analyses -- Rationale for recommendations for use of meningococcal -- Vaccines -- Recommendations for use of meningococcal vaccines -- Future meningococcal vaccines, areas for research, and public education -- References -- Appendix A. Antimicrobial chemoprophylaxis -- Appendix B. Evaluation and management of suspected outbreaks of meningococcal disease

Meningococcal disease describes the spectrum of infections caused by Neisseria meningiditis, including meningitdis, bacteremia, and bacteremic pneumonia. Two quadrivalent meningococcal polysaccharide-protein conjugate vaccines that provide protection against meningococcal serogroups A, C, W, and Y (MenACWY-D [Menactra, manufactured by Sanofi Pasteur, Inc., Swiftwater, Pennsylvania] and MenACWY-CRM [Menveo, manufactured by Novartis Vaccines, Cambridge, Massachusetts]) are licensed in the United States for use among persons aged 2 through 55 years. MenACWY-D also is licensed for use among infants and toddlers aged 9 through 23 months. Quadrivalent meningococcal polysaccharide vaccine (MPSV4 [Menommune, manufactured by sanofi pasteur, Inc., Swiftwater, Pennsylvania]) is the only vaccine licensed for use among persons aged ?56 years. A bivalent meningococcal polysaccharide protein conjugate vaccine that provides protection against meningococcal serogroups C and Y along with Haemophilus influenzae type b (Hib) (Hib-MenCY-TT [MenHibrix, manufactured by GlaxoSmithKline Biologicals, Rixensart, Belgium]) is licensed for use in children aged 6 weeks through 18 months. This report compiles and summarizes all recommendations from CDC&amp;amp;amp;apos;s Advisory Committee on Immunization Practices (ACIP) regarding prevention and control of meningococcal disease in the United States, specifically the changes in the recommendations published since 2005 (CDC. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2005;54[No. RR-7]). As a comprehensive summary of previously published recommendations, this report does not contain any new recommendations; it is intended for use by clinicians as a resource. ACIP recommends routine vaccination with a quadrivalent meningococcal conjugate vaccine (MenACWY) for adolescents aged 11 or 12 years, with a booster dose at age 16 years. ACIP also recommends routine vaccination for persons at increased risk for meningococcal disease (i.e., persons who have persistent complement component deficiencies, persons who have anatomic or functional asplenia, microbiologists who routinely are exposed to isolates of N. meningitidis, military recruits, and persons who travel to or reside in areas in which meningococcal disease is hyperendemic or epidemic). Guidelines for antimicrobial chemoprophylaxis and for evaluation and management of suspected outbreaks of meningococcal disease also are provided.

Pubmed ID:

28448259

Document Type:

Journal Issue

Place as Subject:

United States

Collection(s):

Advisory Committee on Immunization Practices (ACIP)
Guidelines and Recommendations
Stephen B. Thacker CDC Library collection

Main Document Checksum:

[+]

urn:sha256:e89a3734e15dfbb3cc1ec9c8b053e5dd31b5d478a0f7f588290cb4e003808131

Supporting Files:

No Additional Files

Related Documents:

This document has replaced (most recent first):

Prevention and control of meningococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP).

Personal Author:

Rosenstein, Nancy E.; Perkins, Bradley A.;

Corporate Authors:

United States. Advisory Committee on Immunization Practices.. National Center for Infectious Diseases (U.S.). Division of Bacterial and Mycotic Diseases..

Published Date:

June 30, 2000

Source:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2000; 49(RR-7):1-10.

Description:

Introduction -- Methods -- Background -- Meningococcal vaccines -- Postlicensure safety surveillance for meningococcal conjugate vaccines -- Cost-effectiveness analyses -- Rationale for recommendations for use of meningococcal -- Vaccines -- Recommen...

Status:

superseded

File Type:

[PDF - 179.37 KB]
Revised recommendations of the Advisory Committee on Immunization Practices to Vaccinate all Persons Aged 11-18 Years with Meningococcal Conjugate Vaccine

Corporate Authors:

United States. Advisory Committee on Immunization Practices.

Published Date:

August 10, 2007

Source:

MMWR. Morbidity and mortality weekly report. 2007; 56(31):794-5.

Description:

Introduction -- Methods -- Background -- Meningococcal vaccines -- Postlicensure safety surveillance for meningococcal conjugate vaccines -- Cost-effectiveness analyses -- Rationale for recommendations for use of meningococcal -- Vaccines -- Recommen...

Status:

superseded

File Type:

[PDF - 515.21 KB]
Prevention and control of meningococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP)

Personal Author:

Bilukha, Oleg; Rosenstein, Nancy E.;

Corporate Authors:

United States. Advisory Committee on Immunization Practices.. Centers for Disease Control and Prevention (U.S.). National Center for Infectious Diseases (U.S.). Division of Bacterial and Mycotic Diseases..

Published Date:

May 27, 2005

Series:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 49, no. RR-7

Description:

Introduction -- Methods -- Background -- Meningococcal vaccines -- Postlicensure safety surveillance for meningococcal conjugate vaccines -- Cost-effectiveness analyses -- Rationale for recommendations for use of meningococcal -- Vaccines -- Recommen...

Status:

superseded

File Type:

[PDF - 321.91 KB]
Recommendation of the Advisory Committee on Immunization Practices (ACIP) for Use of Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) Among Children Aged 9 Through 23 Months at Increased Risk for Invasive Meningococcal Disease. MMWR 60 (40): 1391-1392.

Corporate Authors:

United States. Advisory Committee on Immunization Practices.

Published Date:

October 14, 2011

Source:

MMWR. Morbidity and mortality weekly report. 2011; 60(40):1391-2.

Description:

Introduction -- Methods -- Background -- Meningococcal vaccines -- Postlicensure safety surveillance for meningococcal conjugate vaccines -- Cost-effectiveness analyses -- Rationale for recommendations for use of meningococcal -- Vaccines -- Recommen...

Status:

superseded

File Type:

[PDF - 64.63 KB]
Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for revaccination of persons at prolonged increased risk for meningococcal disease

Corporate Authors:

United States. Advisory Committee on Immunization Practices.

Published Date:

September 25, 2009

Source:

MMWR. Morbidity and mortality weekly report. 2009; 58(37):1042-3.

Description:

Introduction -- Methods -- Background -- Meningococcal vaccines -- Postlicensure safety surveillance for meningococcal conjugate vaccines -- Cost-effectiveness analyses -- Rationale for recommendations for use of meningococcal -- Vaccines -- Recommen...

Status:

superseded

File Type:

[PDF - 1.49 MB]
Licensure of a meningococcal conjugate vaccine for children aged 2 through 10 years and updated booster dose guidance for adolescents and other persons at increased risk for meningococcal disease--Advisory Committee on Immunization Practices (ACIP), 2011

Corporate Authors:

United States. Advisory Committee on Immunization Practices.

Published Date:

August 11, 2011

Source:

MMWR. Morbidity and mortality weekly report. 2011; 60(30):1018-9.

Description:

Introduction -- Methods -- Background -- Meningococcal vaccines -- Postlicensure safety surveillance for meningococcal conjugate vaccines -- Cost-effectiveness analyses -- Rationale for recommendations for use of meningococcal -- Vaccines -- Recommen...

Status:

superseded

File Type:

[PDF - 72.15 KB]
Control and prevention of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Corporate Authors:

United States. Advisory Committee on Immunization Practices.

Published Date:

February 14, 1997

Source:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1997; 46(RR-5):1-10.

Description:

Introduction -- Methods -- Background -- Meningococcal vaccines -- Postlicensure safety surveillance for meningococcal conjugate vaccines -- Cost-effectiveness analyses -- Rationale for recommendations for use of meningococcal -- Vaccines -- Recommen...

Status:

superseded

File Type:

[HTML]
Meningococcal disease and college students : recommendations of the Advisory Committee on Immunization Practices (ACIP).

Personal Author:

Rosenstein, Nancy E.; Perkins, Bradley A.;

Corporate Authors:

United States. Advisory Committee on Immunization Practices.. National Center for Infectious Diseases (U.S.). Division of Bacterial and Mycotic Diseases..

Published Date:

June 30, 2000

Source:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2000; 49(RR-7):13-20.

Description:

Introduction -- Methods -- Background -- Meningococcal vaccines -- Postlicensure safety surveillance for meningococcal conjugate vaccines -- Cost-effectiveness analyses -- Rationale for recommendations for use of meningococcal -- Vaccines -- Recommen...

Status:

superseded

File Type:

[PDF - 179.37 KB]
Control and prevention of serogroup C meningococcal disease : evaluation and management of suspected outbreaks: recommendations of the Advisory Committee on Immunization Practices (ACIP)

Corporate Authors:

United States. Advisory Committee on Immunization Practices.

Published Date:

February 14, 1997

Source:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1997; 46(RR-5):13-21.

Description:

Introduction -- Methods -- Background -- Meningococcal vaccines -- Postlicensure safety surveillance for meningococcal conjugate vaccines -- Cost-effectiveness analyses -- Rationale for recommendations for use of meningococcal -- Vaccines -- Recommen...

Status:

superseded

File Type:

[HTML]
Report from the Advisory Committee on Immunization Practices (ACIP) : Decision not to recommend routine vaccination of all children aged 2-10 years with quadrivalent meningococcal conjugate vaccine (MCV4)

Published Date:

May 2, 2008

Source:

MMWR. Morbidity and mortality weekly report. 2008; 57(17):462-5.

Description:

Introduction -- Methods -- Background -- Meningococcal vaccines -- Postlicensure safety surveillance for meningococcal conjugate vaccines -- Cost-effectiveness analyses -- Rationale for recommendations for use of meningococcal -- Vaccines -- Recommen...

Status:

superseded

File Type:

[HTML]
Licensure of a meningococcal conjugate vaccine (Menveo) and guidance for use - Advisory Committee on Immunization Practices (ACIP), 2010.

Corporate Authors:

United States. Advisory Committee on Immunization Practices.

Published Date:

March 12, 2010

Source:

MMWR. Morbidity and mortality weekly report. 2010; 59(9):273.

Description:

Introduction -- Methods -- Background -- Meningococcal vaccines -- Postlicensure safety surveillance for meningococcal conjugate vaccines -- Cost-effectiveness analyses -- Rationale for recommendations for use of meningococcal -- Vaccines -- Recommen...

Status:

superseded

File Type:

[PDF - 1.59 MB]
Updated Recommendations for Use of Meningococcal Conjugate Vaccines -- Advisory Committee on Immunization Practices (ACIP), 2010

Corporate Authors:

United States. Advisory Committee on Immunization Practices.

Published Date:

January 28, 2011

Source:

MMWR. Morbidity and mortality weekly report. 2011; 60(3):72-6.

Description:

Introduction -- Methods -- Background -- Meningococcal vaccines -- Postlicensure safety surveillance for meningococcal conjugate vaccines -- Cost-effectiveness analyses -- Rationale for recommendations for use of meningococcal -- Vaccines -- Recommen...

Status:

superseded

File Type:

[HTML]

You May Also Like:

Use of MenACWY-CRM Vaccine in Children Aged 2 Through 23 Months at Increased Risk for Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2013

Personal Author:

MacNeil, Jessica R.; Rubin, Lorry; McNamara, Lucy; Briere, Elizabeth C.; Clark, Thomas A.; Cohn, Amanda C.;

Corporate Authors:

United States. Advisory Committee on Immunization Practices.

Published Date:

Jun 20 2014

Source:

MMWR Morb Mortal Wkly Rep. 2014; 63(24):527-530.

Description:

Introduction -- Methods -- Background -- Meningococcal vaccines -- Postlicensure safety surveillance for meningococcal conjugate vaccines -- Cost-effectiveness analyses -- Rationale for recommendations for use of meningococcal -- Vaccines -- Recommen...

File Type:

[PDF - 146.37 KB]
Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older — United States, 2017

Personal Author:

Kim, David K.; Riley, Laura E.; Harriman, Kathleen H.; Hunter, Paul; Bridges, Carolyn B.;

Corporate Authors:

United States. Advisory Committee on Immunization Practices.

Published Date:

Feb 10 2017

Source:

MMWR Morb Mortal Wkly Rep. 66(5):136-138.

Description:

Introduction -- Methods -- Background -- Meningococcal vaccines -- Postlicensure safety surveillance for meningococcal conjugate vaccines -- Cost-effectiveness analyses -- Rationale for recommendations for use of meningococcal -- Vaccines -- Recommen...

File Type:

[PDF - 84.42 KB]
Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine — Advisory Committee on Immunization Practices, 2016

Personal Author:

Patton, Monica E.; Stephens, David; Moore, Kelly; MacNeil, Jessica R.;

Corporate Authors:

United States. Advisory Committee on Immunization Practices.

Published Date:

May 19 2017

Source:

MMWR Morb Mortal Wkly Rep. 66(19):509-513.

Description:

Introduction -- Methods -- Background -- Meningococcal vaccines -- Postlicensure safety surveillance for meningococcal conjugate vaccines -- Cost-effectiveness analyses -- Rationale for recommendations for use of meningococcal -- Vaccines -- Recommen...

File Type:

[PDF - 142.10 KB]